Corvus Pharmaceuticals reports GAAP EPS of -$0.22, missing by $0.02

Summary

Seeking Alpha reported on November 5, 2026 that Corvus Pharmaceuticals posted GAAP earnings per share of -$0.22, a miss of $0.02. The source item carried only a headline, so it gives no reporting period, revenue figures, or the expectation the result was measured against.

Timeline

1. Seeking Alpha

   5 Nov 2026, 21:03 UTCSource ↗

   Seeking Alpha reports that Corvus Pharmaceuticals posted GAAP EPS of -$0.22, missing by $0.02.